Get the Stockscreener App
83.06
0.89%
0.73
Zimmer Biomet Holdings Inc stock is traded at $83.06, with a volume of 956.57K.
It is up +0.89% in the last 24 hours and up +0.20% over the past month.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
See More
Previous Close:
$82.33
Open:
$82.44
24h Volume:
956.57K
Relative Volume:
0.42
Market Cap:
$16.07B
Revenue:
$8.41B
Net Income/Loss:
$760.80M
P/E Ratio:
21.57
EPS:
3.8513
Net Cash Flow:
$1.05B
1W Performance:
-2.85%
1M Performance:
+0.20%
6M Performance:
-12.34%
1Y Performance:
-9.88%
1-Day Range:
$81.62
$83.65
1-Week Range:
$81.58
$85.68
52-Week Range:
$79.12
$108.29
Zimmer Biomet Holdings Inc Stock (ZBH) Company Profile
Name
Zimmer Biomet Holdings Inc
Sector
Industry
Phone
(574) 267-6131
Address
345 EAST MAIN STREET, WARSAW, IN
Compare ZBH vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ZBH
Zimmer Biomet Holdings Inc
|
83.07 | 15.93B | 8.41B | 760.80M | 1.05B | 3.8513 |
ABT
Abbott Laboratories
|
87.25 | 149.10B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
301.26 | 116.96B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
74.10 | 94.76B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
47.87 | 71.81B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
88.81 | 49.79B | 6.30B | 1.07B | 1.09B | 1.8406 |
Zimmer Biomet Holdings Inc Stock (ZBH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-23-26 | Downgrade | BTIG Research | Buy → Neutral |
| Feb-20-26 | Initiated | William Blair | Mkt Perform |
| Jan-09-26 | Downgrade | Goldman | Neutral → Sell |
| Jan-06-26 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jan-05-26 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-16-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Nov-06-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-18-25 | Initiated | Rothschild & Co Redburn | Buy |
| Jul-15-25 | Upgrade | Roth Capital | Neutral → Buy |
| Dec-17-24 | Upgrade | JP Morgan | Neutral → Overweight |
| Sep-10-24 | Initiated | Wolfe Research | Peer Perform |
| Jul-01-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-30-24 | Initiated | Goldman | Neutral |
| May-21-24 | Upgrade | Argus | Hold → Buy |
| Jan-04-24 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-20-23 | Initiated | ROTH MKM | Neutral |
| Aug-28-23 | Upgrade | BTIG Research | Neutral → Buy |
| May-03-23 | Upgrade | BofA Securities | Underperform → Neutral |
| Apr-11-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Mar-31-23 | Upgrade | Jefferies | Underperform → Hold |
| Mar-29-23 | Initiated | UBS | Sell |
| Mar-10-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jan-09-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jan-05-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Nov-23-22 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-18-22 | Initiated | Barclays | Underweight |
| Oct-12-22 | Initiated | Jefferies | Underperform |
| May-27-22 | Downgrade | Needham | Buy → Hold |
| Apr-13-22 | Downgrade | Truist | Buy → Hold |
| Apr-01-22 | Downgrade | Citigroup | Buy → Neutral |
| Mar-02-22 | Resumed | BofA Securities | Underperform |
| Mar-02-22 | Downgrade | Loop Capital | Buy → Hold |
| Feb-08-22 | Downgrade | Canaccord Genuity | Buy → Hold |
| Feb-08-22 | Reiterated | Citigroup | Buy |
| Feb-08-22 | Reiterated | Deutsche Bank | Hold |
| Feb-08-22 | Reiterated | JMP Securities | Mkt Outperform |
| Feb-08-22 | Reiterated | JP Morgan | Neutral |
| Feb-08-22 | Reiterated | RBC Capital Mkts | Sector Perform |
| Feb-08-22 | Reiterated | Stifel | Buy |
| Feb-08-22 | Reiterated | Truist | Buy |
| Feb-08-22 | Reiterated | UBS | Neutral |
| Feb-08-22 | Reiterated | Wells Fargo | Underweight |
| Feb-02-22 | Downgrade | UBS | Buy → Neutral |
| Jan-19-22 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Jan-10-22 | Downgrade | Mizuho | Buy → Neutral |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-10-21 | Initiated | RBC Capital Mkts | Sector Perform |
| Dec-09-21 | Downgrade | Needham | Strong Buy → Buy |
| Dec-07-21 | Initiated | Loop Capital | Buy |
| Nov-23-21 | Downgrade | Argus | Buy → Hold |
| Sep-14-21 | Resumed | Raymond James | Mkt Perform |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-09-21 | Upgrade | Northland Capital | Market Perform → Outperform |
| Jan-04-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-18-20 | Reiterated | Needham | Strong Buy |
| Oct-20-20 | Initiated | Northland Capital | Market Perform |
| Sep-11-20 | Initiated | Wolfe Research | Outperform |
| Aug-05-20 | Reiterated | Needham | Strong Buy |
| Apr-28-20 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-09-20 | Downgrade | Evercore ISI | Outperform → In-line |
| Apr-07-20 | Reiterated | Needham | Strong Buy |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Buy |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Jan-07-20 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Jan-07-20 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-04-19 | Upgrade | Raymond James | Outperform → Strong Buy |
| Oct-07-19 | Upgrade | BTIG Research | Neutral → Buy |
| Sep-18-19 | Upgrade | Canaccord Genuity | Hold → Buy |
| Aug-12-19 | Upgrade | Argus | Hold → Buy |
| Jul-30-19 | Upgrade | Barclays | Underweight → Equal Weight |
| Jul-29-19 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jun-11-19 | Upgrade | Bernstein | Underperform → Mkt Perform |
| Apr-24-19 | Upgrade | Needham | Buy → Strong Buy |
View All
Zimmer Biomet Holdings Inc Stock (ZBH) Latest News
Thompson Siegel & Walmsley LLC Sells 76,365 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Geode Capital Management LLC Increases Holdings in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Grandfield & Dodd LLC Cuts Stock Holdings in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
[144] ZIMMER BIOMET HOLDINGS, INC. SEC Filing - Stock Titan
United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund Acquires New Shares in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Legal & General Group Plc Has $137.94 Million Holdings in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet Holdings Is Maintained at Neutral by Citigroup - Moomoo
ZBH Technical Analysis | Trend, Signals & Chart Patterns | ZIMMER BIOMET HOLDINGS INC (NYSE:ZBH) - ChartMill
Citigroup Has Lowered Expectations for Zimmer Biomet (NYSE:ZBH) Stock Price - MarketBeat
Goldman Sachs Adjusts PT on Zimmer Biomet to $87 From $86, Maintains Sell Rating - Moomoo
Zimmer (ZBH) Up 3.1% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Citigroup Adjusts Price Target on Zimmer Biomet to $93 From $95, Maintains Neutral Rating - marketscreener.com
Zimmer Biomet 8-K Filing May 22, 2026: NYSE Registered Securities, Entity Information, and Amendment Details - Minichart
Zimmer Biomet Holdings (ZBH) Announces Results of Annual Shareho - GuruFocus
Zimmer Biomet (ZBH) investors approve board slate and pay, reject independent chair bid - Stock Titan
Declaration of Voting Results by Zimmer Biomet - marketscreener.com
Zimmer Biomet Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Zimmer Biomet (NYSE: ZBH) director receives new RSU and phantom unit awards - Stock Titan
Zimmer Biomet (NYSE: ZBH) director receives new RSU and phantom unit grants - Stock Titan
Zimmer Biomet (NYSE: ZBH) director awarded RSU and phantom stock units - Stock Titan
Zimmer Biomet (NYSE: ZBH) director granted Restricted and Phantom Stock Units - Stock Titan
Zimmer Biomet (NYSE: ZBH) director granted RSUs and phantom stock units as compensation - Stock Titan
Zimmer Biomet (NYSE: ZBH) director receives stock and phantom unit awards - Stock Titan
Zimmer Biomet (ZBH) director Arthur Higgins receives new stock and phantom unit grants - Stock Titan
Zimmer Biomet (ZBH) director granted new RSUs and phantom stock awards - Stock Titan
Zimmer Biomet Holdings Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Is Zimmer Biomet Holdings (ZBH) One of the Best Robotic Surgery Stocks to Buy? - Insider Monkey
Zimmer Biomet Holdings, Inc. $ZBH Shares Purchased by Northwestern Mutual Wealth Management Co. - MarketBeat
Cast Saw Devices Market Size Forecast & Industry Trends 2035 - SNS Insider
Zimmer Biomet’s SWOT analysis: stock faces growth headwinds By Investing.com - Investing.com Australia
Zimmer Biomet’s SWOT analysis: stock faces growth headwinds - Investing.com
Morningstar Investment Management LLC Acquires 40,610 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: A Promising 15% Upside with Robust Revenue Growth - DirectorsTalk Interviews
PNC Financial Services Group Inc. Raises Position in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2026 - Sahm
Zimmer Biomet (ZBH) Declares Quarterly Dividend and Raises Share Repurchase Target - GuruFocus
Zimmer Biomet declares $0.24 quarterly dividend By Investing.com - Investing.com Nigeria
Zimmer Biomet declares $0.24 quarterly dividend - Investing.com UK
Zimmer Biomet Holdings, Inc. $ZBH Stake Cut by Heritage Investors Management Corp - MarketBeat
Zimmer Biomet Holdings, Inc. Stock 12‑Month Price Target Cut to $96.45, Implies 13% Upside - TradingView
Zimmer Biomet stock (US98956P1021): earnings and buyback update keep focus on implants - AD HOC NEWS
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Gabelli Funds LLC Boosts Holdings in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Is Zimmer Biomet’s Expanded US$1 Billion Buyback Reshaping the Investment Case for ZBH? - Sahm
Zimmer Biomet Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Suketu Upadhyay sells 31,253 ZBH shares (NYSE: ZBH) - Stock Titan
Zimmer Biomet Holdings, Inc. $ZBH Shares Sold by Independent Advisor Alliance - MarketBeat
Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock - Yahoo Finance
ABT vs. ZBH: Which Surgical Equipment Stock Is the Better Bet Now? - TradingView
Q3 2025 Zimmer Biomet Holdings Inc Earnings Call Transcript - GuruFocus
Zimmer Biomet raises share repurchase target to up to $1B by year-end - MSN
Zimmer Biomet Holdings Inc Stock (ZBH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.42%
1.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):